Dopaminergic system dysfunction in recreational dexamphetamine users - Wikidata - awgldk - TriplyDB

Dopaminergic system dysfunction in recreational dexamphetamine users

Dopaminergic system dysfunction in recreational dexamphetamine users

http://www.wikidata.org/entity/Q35200020

about

Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate.Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls.Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder.Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users.Effects of methylphenidate during emotional processing in amphetamine users: preliminary findings.QT prolongation by dexamphetamine: Does experience matter?

P2860

Q36291652-00373553-BB41-4CF9-950B-786F5A5A6B47 Q37005009-3C2D82E5-E69C-49D6-8CA5-B2486BD2BCC3 Q37607582-509C10BD-A02C-49F5-AB77-49CDE54057FB Q38744676-BA435F3B-70CE-4B92-928E-72CD57F9EB9C Q38891978-2AF99C75-8040-4AE9-81BD-5B411A22038F Q47106264-6C412A4B-E5CA-409C-86BA-216E3F6F3AD8 Q47763367-49E2B80C-85B9-44B9-9635-D1459A5423EB Q48219765-2E283E92-65C4-46BE-B44E-47A989FEC52E

P2860

Dopaminergic system dysfunction in recreational dexamphetamine users

http://www.wikidata.org/entity/Q35200020

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Dopaminergic system dysfunction in recreational dexamphetamine users

@ast

Dopaminergic system dysfunction in recreational dexamphetamine users

@en

type

label

Dopaminergic system dysfunction in recreational dexamphetamine users

@ast

Dopaminergic system dysfunction in recreational dexamphetamine users

@en

prefLabel

Dopaminergic system dysfunction in recreational dexamphetamine users

@ast

Dopaminergic system dysfunction in recreational dexamphetamine users

@en

P1433

Q35200020-12778E39-309A-4CDD-BBD9-A76C415819AD

P1476

Q35200020-5DCF9683-2811-4F8D-B67E-B6A1E5211F5E

P2093

Q35200020-1F07D28C-902B-4B98-B874-5532FFF26A13

Q35200020-6AF2BD88-3907-4C6B-8B7C-E7A4B1F2256B

Q35200020-A72B0E49-391F-4121-959A-3CCEE4AA52DF

Q35200020-BF097D1E-2B62-407A-AB26-7FEEE353616A

Q35200020-C021D563-656F-4CC8-8FD4-51D96B6DE7C2

Q35200020-DF1EE2AC-04C1-49F9-9C0A-CABB0D67462A

Q35200020-E1C293B9-664E-44D4-AB1A-845A1B51A16D

Q35200020-EDD903F8-6C85-429D-836E-C66FB20F4CD3

Q35200020-FA176EF6-4973-45B5-B94A-CD562A82EAB3

P2860

Q35200020-0126C8CC-F2B2-4B74-9F71-92EF14B18528

Q35200020-0A7674B1-3223-4C2B-851E-933B6139590F

Q35200020-15488C5A-B4D6-4B6C-AC87-110DE2AF55A4

Q35200020-212C3E54-04CD-4716-98F8-B128F879D248

Q35200020-28C82B3E-2E28-4902-98A8-D23B1B193AB1

Q35200020-2FA380A4-09D6-4171-8E35-37A9B67B224D

Q35200020-3C8DBE42-D842-4A3C-B4AE-AD51C2B36EC3

Q35200020-4408E318-3233-4432-BB00-2A49E3C012B0

Q35200020-45F47203-58A0-4857-854D-6EE7280F7502

Q35200020-4BE1CBE4-F058-4080-873C-D3107E028FAF

P2888

Q35200020-418B3036-F9B4-4758-A80C-658473A6E1BC

P304

Q35200020-76BB42BB-E3D8-4AC0-917A-8C1478E9082B

P31

Q35200020-E0145778-3B65-4BF0-848C-B9CFEF3B447B

P356

Q35200020-A177C6EB-259A-4DDC-852C-8E32BCBCEF66

P407

Q35200020-A69D5ABC-E6C7-4B28-9D81-E0A3B6392940

P433

Q35200020-6156DBDC-F7C0-4BE9-A913-275B6FF615DF

P478

Q35200020-91449993-E753-42D6-BF5F-00B1DB9058FB

P50

Q35200020-B47C3973-56DD-4686-9D74-56D944B2ED70

P577

Q35200020-4D8A3E4E-27BF-461C-851F-3CE4B21D840D

P6179

Q35200020-51C4588E-E30B-41B6-837C-2FC2C6285CE3

P698

Q35200020-244DF375-5272-490E-B857-F52CFC663126

P921

Q35200020-FEAB8A67-CEDF-401D-B9A5-CC00D71CD55E

P932

Q35200020-0502E3A6-7EFE-4ED4-9CC1-4EE21AF6D51C

P356

P1433

Neuropsychopharmacology

P1476

Dopaminergic system dysfunction in recreational dexamphetamine users

@en

P2093

Aart J Nederveen

http://www.w3.org/2001/XMLSchema#string

Anouk Schrantee

http://www.w3.org/2001/XMLSchema#string

Dennis F R Heijtel

http://www.w3.org/2001/XMLSchema#string

Jan Booij

http://www.w3.org/2001/XMLSchema#string

Lena Václavů

http://www.w3.org/2001/XMLSchema#string

Liesbeth Reneman

http://www.w3.org/2001/XMLSchema#string

Matthan W A Caan

http://www.w3.org/2001/XMLSchema#string

Paul J Lucassen

http://www.w3.org/2001/XMLSchema#string

Willy Gsell

http://www.w3.org/2001/XMLSchema#string

P2860

A fast diffeomorphic image registration algorithm

Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion

Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates

Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

Pseudocontinuous arterial spin labeling reveals dissociable effects of morphine and alcohol on regional cerebral blood flow

Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels.

Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity

Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [¹¹C]raclopride.

Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates.

P2888

P304

1172-1180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2014.301

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Anouk Schrantee

P577

2015-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021646195

http://www.w3.org/2001/XMLSchema#string

P698

25394786

http://www.w3.org/2001/XMLSchema#string

P921

P932

4367461

http://www.w3.org/2001/XMLSchema#string